Paul Docherty

• 
  Opinion

  Gone to completion

  2013-11-26T00:00:00

  After a 66-step journey, Paul Docherty ponders the future of total synthesis in his final column

• 
  Opinion

  Marcfortines B & C

  2013-11-05T00:00:00

  Paul Docherty ponders a tasty cheeseboard as a source of synthetic inspiration

• 
  Opinion

  Scholarisine A

  2013-09-26T00:00:00

  Paul Docherty marvels at a parade of intricate radical reactions

• 
  Opinion

  Steviol

  2013-09-02T00:00:00

  Sculpting a molecule from a larger whole is an unusual but effective strategy, says Paul Docherty

• Opinion

  Melotenine A

  2013-07-30T00:00:00

  Paul Docherty extols the virtues of chiral heteroatoms

• Opinion

  Bolivianine

  2013-06-27T00:00:00

  A complex terpene gives Paul Docherty a headache

• Opinion

  Pactamycin

  2013-05-29T00:00:00

  Labelling a molecule 'inaccessible to synthesis' is a red rag to a bull, says Paul Docherty

• Opinion

  Kingianin A

  2013-05-01T00:00:00

  Paul Docherty faces his fears of frontier molecular orbital theory

• Opinion

  Acutumine

  2013-03-22T00:00:00

  Polycyclic acutumine ties Paul Docherty up in knots

• Opinion

  Lyconadin A

  2013-02-28T00:00:00

  Paul Docherty tackles a serious repeat offender

• Opinion

  Hyperforin

  2013-01-24T00:00:00

  A flexible natural product synthesis is the key to later drug development

• Opinion

  Flueggine A

  2013-01-02T00:00:00

  Some exotic heterocyclic chemistry catches Paul Docherty's eye

• Opinion

  Pentalenolactone A methyl ester

  2012-11-27T00:00:00

  Paul Docherty revises a reaction he never could quite remember

• Opinion

  Epicoccin G

  2012-10-31T00:00:00

  Paul Docherty gets to grips with some thiodiketopiperazines

• Opinion

  Prostaglandin F2α

  2012-10-01T00:00:00

  Paul Docherty comes face to face with an old adversary

• Opinion

  Amphidinolide F

  2012-08-29T00:00:00

  Symmetry in natural products isn’t always so apparent

• Opinion

  Marinomycin A

  2012-07-27T00:00:00

  Faced with the term ‘polymer’, most people would consider man-made materials

• Opinion

  Vincorine

  2012-07-01T00:00:00

  Cage-structured natural products are some of the most appealing targets for organic chemists

• Opinion

  atrop-Abyssomicin C

  2012-05-31T00:00:00

  Natural products frequently have hard to pronounce and even harder to spell names, often of little meaning.

• Opinion

  Hopeahainol A and hopeanol

  2012-04-30T00:00:00

  This month's synthesis looks somewhat familiar

More by Paul Docherty